Challenges in the development of magnetic particles for therapeutic applications
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Hyperthermia
- Vol. 24 (6), 451-466
- https://doi.org/10.1080/02656730802093679
Abstract
Certain iron-based particle formulations have useful magnetic properties that, when combined with low toxicity and desirable pharmacokinetics, encourage their development for therapeutic applications. This mini-review begins with background information on magnetic particle use as MRI contrast agents and the influence of material size on pharmacokinetics and tissue penetration. Therapeutic investigations, including (1) the loading of bioactive materials, (2) the use of stationary, high-gradient (HG) magnetic fields to concentrate magnetic particles in tissues or to separate material bound to the particles from the body, and (3) the application of high power alternating magnetic fields (AMF) to generate heat in magnetic particles for hyperthermic therapeutic applications are then surveyed. Attention is directed mainly to cancer treatment, as selective distribution to tumors is well-suited to particulate approaches and has been a focus of most development efforts. While magnetic particles have been explored for several decades, their use in therapeutic products remains minimal; a discussion of future directions and potential ways to better leverage magnetic properties and to integrate their use into therapeutic regimens is discussed.Keywords
This publication has 100 references indexed in Scilit:
- Recent advances in iron oxide nanocrystal technology for medical imagingAdvanced Drug Delivery Reviews, 2006
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomasProceedings of the National Academy of Sciences of the United States of America, 2006
- Development of a macrophage-based nanoparticle platform for antiretroviral drug deliveryBlood, 2006
- Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRIStroke, 2006
- Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulationsJournal of Inorganic Biochemistry, 2004
- Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancerInternational Journal of Clinical Oncology, 2004
- Applications of magnetic nanoparticles in biomedicineJournal of Physics D: Applied Physics, 2003
- Detection of disseminated tumor cells in peripheral blood of colorectal cancer patientsInternational Journal of Cancer, 1997
- Magnetic urokinase: Targeting of urokinase to fibrin clotBiochemical and Biophysical Research Communications, 1988
- Fibrinolysis by urokinase endowed with magnetic propertyBiochemical and Biophysical Research Communications, 1987